Abstract

Meta-analysis and dose estimation. The aim of this study was to estimate radiation dose during minimally invasive transforaminal lumbar interbody fusion (MiTLIF) compared with open transforaminal lumbar interbody fusion (OTLIF) and evaluate the risk of radiation-related disease. MiTLIF was introduced to reduce soft tissue injury and shows favorable perioperative outcomes. However, the disadvantage of MiTLIF is that, compared with OTLIF, it involves high radiation exposure because MiTLIF usually depends on a fluoroscopic guide. The additional cancer risk due to medical radiation exposure during the MiTLIF procedure has not yet been assessed. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials in June 2014 for studies directly comparing MiTLIF and OTLIF. Patient demographics, fluoroscopy time, intraoperative bleeding, and hospitalization period were extracted. The effective dose was converted from fluoroscopy time using formulas from prior studies. Eight cohort studies with a total of 619 patients were identified. Mean fluoroscopy time was 39.42 seconds [95% confidence interval (CI), 38.01-40.83] during OTLIF and 94.21 seconds (95% CI, 91.51-96.91) during MiTLIF according to the meta-analysis. The pooled data revealed that patients who underwent MiTLIF were exposed to 2.4-fold more radiation than those who underwent OTLIF. Patients who underwent OTLIF and MiTLIF were exposed to 0.66 mSv (95% CI, 0.64-0.69) and 1.58 mSv (95% CI, 1.54-1.63) during the surgery, respectively. The lifetime risk of cancer was theoretically increased by 36.4×10 and 87.0×10 after OTLIF and MiTLIF, respectively. The risk of detrimental hereditary disorders associated with OTLIF and MiTLIF is 1.32×10 and 3.16×10, respectively. Patients who underwent MiTLIF were exposed to 2.4-fold more radiation than those who underwent OTLIF. Although the theoretical cancer risk associated with radiation exposure may be tolerable, stochastic effects should not be disregarded.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.